The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of rituximab plus FAB group C chemotherapy without CNS radiation in CNS-positive pediatric Burkitt lymphoma/leukemia: A report from the Children’s Oncology Group.
J. Kimble Frazer
No relevant relationships to disclose
Stanton Goldman
No relevant relationships to disclose
Lynette Smith
No relevant relationships to disclose
Lauren Harrison
No relevant relationships to disclose
Sherrie L Perkins
No relevant relationships to disclose
Mitchell S. Cairo
No relevant relationships to disclose